Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies-Reference-Cited by-同舟云学术

Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies

Published:2018-09-12 Issue:3 Volume:19 Page:305-314
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Robinson Katherine M.,Yang Wenjian,Haidar Cyrine E.,Hankins Jane S.,Jay Dennis W.,Kornegay Nancy,Rubnitz Jeffrey E.,Broeckel Ulrich,Cheng Cheng,Pui Ching-Hon,Jeha Sima,Relling Mary V.

Funder

U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/s41397-018-0043-3.pdf

Reference52 articles.

1. Luzzatto L, Nannelli C, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Hematol Oncol Clin North Am. 2016;30:373–93.

2. Pandolfi PP, Sonati F, Rivi R, Mason P, Grosveld F, Luzzatto L. Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J. 1995;14:5209–15.

3. Sivilotti ML. Oxidant stress and haemolysis of the human erythrocyte. Toxicol Rev. 2004;23:169–88.

4. Mason PJ, Bautista JM, Gilsanz F. G6PD deficiency: the genotype-phenotype association. Blood Rev. 2007;21:267–83.

5. McDonagh EM, Bautista JM, Youngster I, Altman RB, Klein TE. PharmGKB summary: methylene blue pathway. Pharm Genom. 2013;23:498–508.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype;Clinical Pharmacology & Therapeutics;2022-09-24

2. Impact of pre‐emptive rapid testing for glucose‐6‐phosphate dehydrogenase deficiency prior to rasburicase administration at a tertiary care centre: A retrospective study;British Journal of Clinical Pharmacology;2022-05-02

3. Incorporating G6PD genotyping to identify patients with G6PD deficiency;Pharmacogenetics and Genomics;2021-10-22

4. Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case–control data from Bangladesh;PLOS Medicine;2021-04-23

5. Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, Bangladesh;PLOS Neglected Tropical Diseases;2020-09-14